180 related articles for article (PubMed ID: 18695675)
1. Functional long-range interactions of the IgH 3' enhancers with the bcl-2 promoter region in t(14;18) lymphoma cells.
Duan H; Xiang H; Ma L; Boxer LM
Oncogene; 2008 Dec; 27(53):6720-8. PubMed ID: 18695675
[TBL] [Abstract][Full Text] [Related]
2. The immunoglobulin heavy-chain gene 3' enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells.
Duan H; Heckman CA; Boxer LM
Oncogene; 2007 Apr; 26(18):2635-41. PubMed ID: 17043638
[TBL] [Abstract][Full Text] [Related]
3. Direct interactions of OCA-B and TFII-I regulate immunoglobulin heavy-chain gene transcription by facilitating enhancer-promoter communication.
Ren X; Siegel R; Kim U; Roeder RG
Mol Cell; 2011 May; 42(3):342-55. PubMed ID: 21549311
[TBL] [Abstract][Full Text] [Related]
4. A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14;18) cell lines.
Capaccioli S; Quattrone A; Schiavone N; Calastretti A; Copreni E; Bevilacqua A; Canti G; Gong L; Morelli S; Nicolin A
Oncogene; 1996 Jul; 13(1):105-15. PubMed ID: 8700536
[TBL] [Abstract][Full Text] [Related]
5. Oct transcription factors mediate t(14;18) lymphoma cell survival by directly regulating bcl-2 expression.
Heckman CA; Duan H; Garcia PB; Boxer LM
Oncogene; 2006 Feb; 25(6):888-98. PubMed ID: 16186795
[TBL] [Abstract][Full Text] [Related]
6. The immunoglobulin heavy chain locus control region increases histone acetylation along linked c-myc genes.
Madisen L; Krumm A; Hebbes TR; Groudine M
Mol Cell Biol; 1998 Nov; 18(11):6281-92. PubMed ID: 9774645
[TBL] [Abstract][Full Text] [Related]
7. Regulatory elements in the immunoglobulin heavy chain gene 3'-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells.
Wang J; Boxer LM
J Biol Chem; 2005 Apr; 280(13):12766-73. PubMed ID: 15687498
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitor Trichostatin A reduces anti-DNA autoantibody production and represses IgH gene transcription.
Lu ZP; Ju ZL; Shi GY; Zhang JW; Sun J
Biochem Biophys Res Commun; 2005 Apr; 330(1):204-9. PubMed ID: 15781251
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas.
Duan H; Heckman CA; Boxer LM
Mol Cell Biol; 2005 Mar; 25(5):1608-19. PubMed ID: 15713621
[TBL] [Abstract][Full Text] [Related]
10. The Ig heavy chain 3' end confers a posttranscriptional processing advantage to Bcl-2-IgH fusion RNA in t(14;18) lymphoma.
Petrovic AS; Young RL; Hilgarth B; Ambros P; Korsmeyer SJ; Jaeger U
Blood; 1998 May; 91(10):3952-61. PubMed ID: 9573034
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic silencing of the immunoglobulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglobulin expression.
Ushmorov A; Ritz O; Hummel M; Leithäuser F; Möller P; Stein H; Wirth T
Blood; 2004 Nov; 104(10):3326-34. PubMed ID: 15284123
[TBL] [Abstract][Full Text] [Related]
12. Deregulated PAX-5 transcription from a translocated IgH promoter in marginal zone lymphoma.
Morrison AM; Jäger U; Chott A; Schebesta M; Haas OA; Busslinger M
Blood; 1998 Nov; 92(10):3865-78. PubMed ID: 9808580
[TBL] [Abstract][Full Text] [Related]
13. NF-kappa B and Oct-2 synergize to activate the human 3' Igh hs4 enhancer in B cells.
Sepulveda MA; Emelyanov AV; Birshtein BK
J Immunol; 2004 Jan; 172(2):1054-64. PubMed ID: 14707079
[TBL] [Abstract][Full Text] [Related]
14. Deregulation of PAX-5 by translocation of the Emu enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma.
Busslinger M; Klix N; Pfeffer P; Graninger PG; Kozmik Z
Proc Natl Acad Sci U S A; 1996 Jun; 93(12):6129-34. PubMed ID: 8650231
[TBL] [Abstract][Full Text] [Related]
15. The immunoglobulin heavy chain gene 3' enhancers induce Bcl2 deregulation and lymphomagenesis in murine B cells.
Xiang H; Noonan EJ; Wang J; Duan H; Ma L; Michie S; Boxer LM
Leukemia; 2011 Sep; 25(9):1484-93. PubMed ID: 21606958
[TBL] [Abstract][Full Text] [Related]
16. NF-kappa B activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer.
Kanda K; Hu HM; Zhang L; Grandchamps J; Boxer LM
J Biol Chem; 2000 Oct; 275(41):32338-46. PubMed ID: 10931834
[TBL] [Abstract][Full Text] [Related]
17. [Primary ocular adnexal lymphoproliferative lesions: clinicopathologic features and genetic alterations].
Dong LN; Liu HG; Jin HS; Ye HT; Gao ZF; Zhou XG; Dong GH; Zhang DD; Gong LP
Zhonghua Bing Li Xue Za Zhi; 2008 Dec; 37(12):809-14. PubMed ID: 19159526
[TBL] [Abstract][Full Text] [Related]
18. Critical elements of the immunoglobulin heavy chain gene enhancers for deregulated expression of bcl-2.
Heckman CA; Cao T; Somsouk L; Duan H; Mehew JW; Zhang CY; Boxer LM
Cancer Res; 2003 Oct; 63(20):6666-73. PubMed ID: 14583460
[TBL] [Abstract][Full Text] [Related]
19. Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1.
Nagel S; Scherr M; Kel A; Hornischer K; Crawford GE; Kaufmann M; Meyer C; Drexler HG; MacLeod RA
Cancer Res; 2007 Feb; 67(4):1461-71. PubMed ID: 17308084
[TBL] [Abstract][Full Text] [Related]
20. Morphologic transformation of follicular lymphoma is associated with somatic mutation of the translocated Bcl-2 gene.
Matolcsy A; Casali P; Warnke RA; Knowles DM
Blood; 1996 Nov; 88(10):3937-44. PubMed ID: 8916960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
